Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Dave Stuart's group have studied the structure of the Ebola virus and the effect of two drugs, toremifene and ibruprofen on the virus. The study was the first to solve the unligated structure of the Ebola virus glycoprotein and the results were published in Nature. Professor Stuart told the Independent newspaper: “This information can guide the design of more powerful anti-Ebola drugs. My group will be continuing this project at Diamond … which should help us to further accelerate the rational drug design process. "We hope this research will lead to new drugs that can help to save lives if we are faced with further outbreaks of the disease in the future.”